Advarra Survey Finds Increased Burden on Clinical Trial Sites


Two-thirds of respondents believe setup and training on trial sponsor technology are more problematic than five years ago.

medical or scientific researcher researching and experimenting Multi-colored solution, vial and microscope In the laboratory or in the laboratory by wearing blue gloves and white clothing completely. Image Credit: Adobe Stock Images/ThawKyar

Image Credit: Adobe Stock Images/ThawKyar

Advarra revealed findings from its 2023 Study Activation Survey indicating increases in site burden since 2018. According to the report, around 60% of sites say their study volume is higher plus they are managing more sponsor-provided technology, which was rated a higher burden than contracting and budgeting. Furthermore, 55% of sites report setup and training on sponsor technology to be extremely or very burdensome, and 67% say it's gotten worse in the past five years.

"Sites are increasingly saddled with complex technologies and duplicative, administrative tasks.We need to come together as an industry and support both sites and sponsors with technology that works for each stakeholder respectively and helps improve clinical research – not hinder it," said Gadi Saarony, CEO, Advarra."Advarra uniquely knows and understands the needs of sponsors, CROs, sites, and participants and is committed to driving industrywide stakeholder collaboration and to be the pioneer in connecting the clinical research ecosystem."

Reference: New Clinical Trial Industry Survey Reveals Increased Burdens on Sites. PR Newswire. October 17, 2023. Accessed October 19, 2023.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.